Methods for producing enriched populations of human retinal pigment epithelium cells
First Claim
Patent Images
1. A method of treating retinal disease or condition in an human subject, comprising transplanting into the eye of said subject a composition comprising an allogeneic human pigmented cell population comprising bestrophin+/CRALBP+ cells obtained by in vitro differentiation of human pluripotent cells that express Oct-4, alkaline phosphatase, SSEA-3, SSEA-4, TRA-I-60, and TRA-I-81, wherein the human pigmented cell population has a normal karyotype.
7 Assignments
0 Petitions
Accused Products
Abstract
This invention relates to methods for improved cell-based therapies for retinal degeneration and for differentiating human embryonic stem cells and human embryo-derived into retinal pigment epithelium (RPE) cells and other retinal progenitor cells.
53 Citations
19 Claims
- 1. A method of treating retinal disease or condition in an human subject, comprising transplanting into the eye of said subject a composition comprising an allogeneic human pigmented cell population comprising bestrophin+/CRALBP+ cells obtained by in vitro differentiation of human pluripotent cells that express Oct-4, alkaline phosphatase, SSEA-3, SSEA-4, TRA-I-60, and TRA-I-81, wherein the human pigmented cell population has a normal karyotype.
Specification